Gitte Pedersen | RNA Diagnostics and the Future of Precision Oncology
Gitte Pedersen joins Executive Insights for Life Sciences Innovators to discuss RNA-based diagnostics, precision oncology, genomic data, and building life sciences companies at the intersection of biology, technology, and patient care.
Prefer audio only? Listen to this episode on Spotify.
Episode Overview
In this episode, Gitte Pedersen discusses how Genomic Expression is using RNA-based diagnostics to help clinicians identify more effective treatment options for cancer patients. The conversation explores precision oncology, RNA sequencing, the challenges of translating genomic data into clinical decision tools, and the realities of scaling mission-driven diagnostics companies in healthcare.
Key Themes
- RNA-based diagnostics in precision oncology
- Translating genomic data into clinical decision tools
- RNA sequencing and cancer treatment selection
- Building diagnostics companies in life sciences
- The intersection of biology, data, and patient care
- Scaling mission-driven healthcare innovation
Why This Matters for Life Sciences Leaders
As precision medicine continues to evolve, life sciences leaders are increasingly focused on how advanced diagnostics and genomic technologies can improve clinical decision-making and patient outcomes. The conversation highlights the opportunities and challenges involved in translating complex biological data into scalable healthcare solutions while balancing scientific rigor, operational execution, and commercial adoption.
Guest Link
More from Executive Insights
Explore more conversations with life sciences founders, CEOs, investors, and operators on the Executive Insights for Life Sciences Innovators podcast.
